Zobrazeno 1 - 10
of 301
pro vyhledávání: '"Dennis A, Gastineau"'
Autor:
Michael P Gustafson, Dennis A Gastineau, Bruce D Johnson, Richard J Simpson, Courtney M Wheatley-Guy, Allison C Rosenthal, Emmanuel Katsanis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
The remarkable success of cancer immunotherapies has provided new hope to cancer patients. Unfortunately, a significant proportion of patients remain unable to respond to immunotherapy or maintain durable clinical responses. The lack of objective res
Externí odkaz:
https://doaj.org/article/0049e0d2c2924106a48ae4cba836a50f
Autor:
Michael P. Gustafson, PhD, Svetlana Bornschlegl, BS, Sean S. Park, MD, PhD, Dennis A. Gastineau, MD, Lewis R. Roberts, MB, ChB, PhD, Allan B. Dietz, PhD, Christopher L. Hallemeier, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 4, Pp 540-547 (2017)
Stereotactic body radiation therapy (SBRT) can positively influence an antitumor immune response by inducing necrotic cell death. SBRT also been shown to eliminate tumors outside the radiation therapy field through an immune-mediated process known as
Externí odkaz:
https://doaj.org/article/749f2688ad544dec92507c295afa1acd
Autor:
Michael P. Gustafson, Ara Celi DiCostanzo, Courtney M. Wheatley, Chul-Ho Kim, Svetlana Bornschlegl, Dennis A. Gastineau, Bruce D. Johnson, Allan B. Dietz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-14 (2017)
Abstract Background Exercise immunology has become a growing field in the past 20 years, with an emphasis on understanding how different forms of exercise affect immune function. Mechanistic studies are beginning to shed light on how exercise may imp
Externí odkaz:
https://doaj.org/article/b45a5d561f944e9091cbcf456ca0c84c
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Recent successes in cancer immunotherapy have been tempered by sub-optimal clinical responses in the majority of patients. The impaired anti-tumor immune responses observed in these patients are likely a consequence of immune system dysfunction contr
Externí odkaz:
https://doaj.org/article/11a7490a2f674d479acb8ab8f2838e74
Autor:
Darcie J. Radel, Allan B. Dietz, Michael C. Deeds, Clint S. Schmidt, Eapen K. Jacob, Julia M. Thebiay, Linda L. Pelleymounter, Timothy D. Wiltshire, Alexander M. Bornschlegl, James R. Stubbs, Dennis A. Gastineau
Publikováno v:
Cytotherapy. 24:19-26
Background The rise of investigative and commercially available cell therapy products adds a new dynamic to academic medical centers; that is, the management of patient-specific cell products. The scope of cell therapy has rapidly expanded beyond in-
Autor:
Allan B. Dietz, Eugene D. Kwon, John C. Cheville, Bradley C. Leibovich, Dennis A. Gastineau, Rebecca R. Laborde, Susan M. Harrington, Peggy A. Bulur, Paul L. Crispen, Matthew K. Tollefson, Deepti Warad, Jonathan S. Bleeker, Yi Lin, Michael P. Gustafson
Supplemental Table 2. Univariate and multivariable associations of CD14 expression with death from RCC for 375 patients with ccRCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9cb098c6f818c762b09bffe7af7dd3
https://doi.org/10.1158/1078-0432.22456577.v1
https://doi.org/10.1158/1078-0432.22456577.v1
Autor:
Allan B. Dietz, Eugene D. Kwon, John C. Cheville, Bradley C. Leibovich, Dennis A. Gastineau, Rebecca R. Laborde, Susan M. Harrington, Peggy A. Bulur, Paul L. Crispen, Matthew K. Tollefson, Deepti Warad, Jonathan S. Bleeker, Yi Lin, Michael P. Gustafson
Supplemental Figure 4. Co-cultures of CD14+ monocytes and other renal cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b93f48644a82ab5511865daafe65b6b7
https://doi.org/10.1158/1078-0432.22456583
https://doi.org/10.1158/1078-0432.22456583
Autor:
Allan B. Dietz, Eugene D. Kwon, John C. Cheville, Bradley C. Leibovich, Dennis A. Gastineau, Rebecca R. Laborde, Susan M. Harrington, Peggy A. Bulur, Paul L. Crispen, Matthew K. Tollefson, Deepti Warad, Jonathan S. Bleeker, Yi Lin, Michael P. Gustafson
Supplemental Figure 3. Distribution of 3 subpopulations of monocytes in RCC patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53162792d03d0362751644fb1b0de09d
https://doi.org/10.1158/1078-0432.22456586.v1
https://doi.org/10.1158/1078-0432.22456586.v1
Autor:
Allan B. Dietz, Eugene D. Kwon, John C. Cheville, Bradley C. Leibovich, Dennis A. Gastineau, Rebecca R. Laborde, Susan M. Harrington, Peggy A. Bulur, Paul L. Crispen, Matthew K. Tollefson, Deepti Warad, Jonathan S. Bleeker, Yi Lin, Michael P. Gustafson
Legend for Supplemental Figure 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a72f4abe241d38003a6e44004afcad8
https://doi.org/10.1158/1078-0432.22456595
https://doi.org/10.1158/1078-0432.22456595
Autor:
Allan B. Dietz, Eugene D. Kwon, John C. Cheville, Bradley C. Leibovich, Dennis A. Gastineau, Rebecca R. Laborde, Susan M. Harrington, Peggy A. Bulur, Paul L. Crispen, Matthew K. Tollefson, Deepti Warad, Jonathan S. Bleeker, Yi Lin, Michael P. Gustafson
Purpose: Immunotherapeutic strategies to treat patients with renal cell carcinoma (RCC) offer new opportunities for disease management. Further improvements to immunotherapy will require additional understanding of the host response to RCC developmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e31020ee6152388c441503c342751a1
https://doi.org/10.1158/1078-0432.c.6523358.v1
https://doi.org/10.1158/1078-0432.c.6523358.v1